The GEO Group’s Earnings Call Contradictions: ISAP Growth Timeline Clashes With ICE Bed Capacity Strategy

Date of Call: Aug 6, 2026

Financials Results

• Revenue: $732.1 million, up 15% YOY
• EPS: $0.36 per diluted share, up 71% YOY

Guidance:

• Increased full-year 2026 GAAP net income guidance to $168M-$175M ($1.27-$1.32 per diluted share).
• Increased full-year 2026 adjusted EBITDA guidance to $550M-$560M.
• Q3 2026 GAAP net income expected $45M-$48M ($0.35-$0.37 per diluted share); adjusted EBITDA $140M-$145M.
• Q4 2026 GAAP net income expected $37M-$41M ($0.28-$0.31 per diluted share); adjusted EBITDA $137M-$142M.
• Full-year 2026 unreimbursed CapEx expected $135M-$145M; CapEx to decline below $100M in 2027.

Business Commentary:

Revenue and Net Income Growth:

• The GEO Group reported a 15% increase in revenues for Q2 2026, from $636.2 million to $732.1 million, and a 63% increase in net income, from $29.1 million to $47.5 million.
• This growth was driven by significant revenue growth from new contracts awarded in 2025, including new or expanded contracts representing up to approximately $520 million in annual revenues.

ICE Contract Expansion and Detention Capacity:

• The company increased its total active ICE beds to approximately 27,000, with a 20% increase in ICE population over the last six weeks due to the Secure America Act.
• This reflects ICE's priority to increase immigration detention capacity to 100,000 beds or more and consolidate to fewer larger facilities.

ISAP-5 Contract and Technology Mix Shift:

• The ISAP-5 contract saw a significant increase in participants on GPS ankle monitors, from 17,000 early 2025 to 54,000 currently, out of a total of 184,000 participants.
• The shift to more intensive and higher-priced monitoring devices is increasing revenues and earnings under the ISAP contract.

Transportation Services Expansion:

• The company's secure transportation services revenues are expected to increase by approximately $20 million annually once normalized in early 2027 from the new Bighorn and Rivers contracts.
• This growth is part of an expansion in secure ground and air transportation services for ICE and the U.S. Marshals Service.

Potential Upside and Future Opportunities:

• The GEO Group has identified potential upside from additional growth in secure services, ISAP contract technology mix, transportation services, and higher utilization of the skip tracing contract.
• The company also highlighted potential revenue from additional idle facilities and expects the activation of two new facilities to add approximately $165 million in annual revenues in 2027.

Sentiment Analysis:

Overall Tone: Positive

• “Our diversified business units continue to deliver strong financial and operational performance... Revenues increased 15%... net income increased 63%... We are very pleased with our strong second quarter results and the improved full-year outlook... We believe our stock continues to be significantly undervalued and offers a very attractive investment opportunity.”

Q&A:

• Question from Joe Gomes (Noble Capital): Could you give more insight on why the Florida facilities were pushed out a year? Was that revenue in prior guidance, and would guidance be higher without the push out?
  Response: Yes, the push out was due to unresolved budgetary issues; the prior guidance included expected revenue from these contracts, and guidance would have been raised higher without the delay.

• Question from Joe Gomes (Noble Capital): Is ICE reimbursing for CapEx in new contracts new, and does it relate to reduced CapEx guidance?
  Response: It is relatively new; the reduction in ongoing CapEx is due to completion of startup costs and a shift to normal maintenance expenditures.

• Question from Brendan McCarthy: Is it still expected ICE will reach 100,000 operational beds before turning to ISAP?
  Response: Yes, the focus is on increasing detention capacity to about 100,000 beds, with an objective of consolidating into fewer, larger facilities.

• Question from Brendan McCarthy: Is $60M still a reasonable annualized revenue estimate for the skip tracing contract? What are trends?
  Response: Yes, that estimate is correct, and another contract is expected this quarter.

• Question from Brendan McCarthy: On potential facility sales, does timing line up with renewals this fall?
  Response: The procurement process for four facilities is ongoing, with hopes to complete it by end of this quarter, involving a new long-term contract term.

• Question from Greg (Noble Capital): Post-asset sales, how are you thinking about capital allocation? Target net leverage? Buybacks vs. 1031 exchange?
  Response: Proceeds would be deployed to debt repayment and returning capital to shareholders via share repurchases or other remuneration, subject to debt agreement restrictions.

• Question from Greg (Noble Capital): Could ICE's push to use monitoring for Haitian immigrants change ISAP population? What's the impact of moving from SmartLink to ankle monitoring?
  Response: Yes, policy shifts could increase ISAP participants, likely placed on more expensive ankle monitors, impacting revenue positively.

• Question from Kirk Lutke (Raymond James): How many beds might come from ICE's own facility building efforts?
  Response: Approximately 5,000 beds from activating 2-3 facilities; the main effort is reactivating former BOP facilities for high-security detention.

• Question from Kirk Lutke (Raymond James): Is there a time limit on funding for this effort?
  Response: ICE has approximately $36B allocated through the president's current term (about three years) for facility buildup.

• Question from Kirk Lutke (Raymond James): Can you elaborate on geographic considerations for facility acquisitions?
  Response: Geographic considerations refer to differences in facility costs across states (e.g., Oklahoma vs. Colorado), with appraisals based on replacement cost in each location.

Contradiction Point 1

Timing for Significant ISAP Program Growth

Inconsistent timeline for when ISAP participant numbers could increase significantly.

Joe Gomes (Noble Capital), what are your expectations for the company's revenue growth this quarter? - Joe Gomes (Noble Capital)

2026Q2: While ISAP is a program for the non-detained population, significant increases in ISAP participants could occur in the future, potentially next year, depending on policy shifts... - George Zoli(CEO)

Given the ISAP contract's two-year flat revenue and past growth expectations, what is the outlook for ISAP participant numbers and ICE's focus on this program? - Joe Gomes (Noble Capital)

2026Q2: The current focus for ICE is "increasing detention capacity," not the ISAP program. However, "at a later point, maybe next year, we could see ISAP increase dramatically." - George Zoley(CEO)

Contradiction Point 2

Primary Source of Beds for ICE's 100,000-Bed Target

Contradiction on whether new facilities are being built or only existing ones reactivated.

Kirk Lutke (Raymond James) - Kirk Lutke (Raymond James)

2026Q2: The company does not believe ICE is building new facilities from scratch. The effort is focused on reactivating former BOP facilities. - George Zoli(CEO)

How many beds in ICE's 100,000 target might come from ICE's own facility-building efforts? - Kirk Ludtke (Raymond James)

2026Q2: ICE is not building new facilities but "reactivating... formerly BOP facilities" that were discontinued. - George Zoley(CEO)

Contradiction Point 3

Timeline and Expectation for ICE Facility Sales

Conflicting statements on when facility sales might be realized.

Brendan McCarthy - Brendan McCarthy

2026Q2: There is a mutual interest to complete the process by the end of Q3 2026, though it could spill over into Q4. - George Zoli(CEO)

Could the timing of potential facility sales to ICE align with the contract renewals for four facilities up for recompetition this fall? - Greg Gibas (Northland Securities)

2026Q1: Guess at late Q2 and maybe early Q3. - George Zoley(CEO)

Contradiction Point 4

Outlook for ISAP Program Growth

Inconsistency in the expected priority of ISAP program expansion relative to detention capacity.

Brendan McCarthy - Brendan McCarthy

2026Q2: ICE's current focus is primarily on increasing immigration detention capacity to around 100,000 beds. While ISAP is a program for the non-detained population, significant increases in ISAP participants could occur in the future, potentially next year... - George Zoli(CEO)

Does ICE still expect to reach 100,000 operational beds before expanding the ISAP program? - Raj Sharma (Texas Capital)

2026Q1: The objective to increase nationwide capacity to ~100,000 and consolidate to fewer facilities remains. The private sector (GEO with 6,000 beds and CoreCivic with ~10,000 beds) can provide a meaningful increase in capacity at a favorable cost. - George Zoley(CEO)

Contradiction Point 5

ICE's Capacity-Building Strategy and Facility Acquisition Focus

Contradiction on whether ICE is building new facilities or focusing on reactivating existing ones.

Kirk Lutke (Raymond James) - Kirk Lutke (Raymond James)

2026Q2: The effort is focused on reactivating former BOP facilities. Of the 11 facilities recently acquired, maybe 2-3 are being activated, adding around 5,000 beds. - George Zoli(CFO)

How many beds of ICE's 100,000 target will come from their own facility-building efforts? - Joseph Gomes (NOBLE Capital Markets, Inc.)

2025Q4: ICE is pursuing a dual-track approach: utilizing the private sector and exploring the warehouse initiative. The private sector's available capacity is insufficient to reach 100,000 beds; GEO estimates the warehouse initiative would need to add at least 20,000 beds. - George Zoley(CFO)